1. Hu, Ming, Cebola, Inês, Carrat, Gaelle, McMahon, Harvey, Rutter, Guy A. . Chromatin 3D interaction analysis of the STARD10 locus unveils FCHSD2 as a regulator of insulin secretion. In Cell reports, 34, 108703. doi:10.1016/j.celrep.2021.108703. https://pubmed.ncbi.nlm.nih.gov/33535042/
2. Xiao, Guan-Yu, Schmid, Sandra L. 2020. FCHSD2 controls oncogenic ERK1/2 signaling outcome by regulating endocytic trafficking. In PLoS biology, 18, e3000778. doi:10.1371/journal.pbio.3000778. https://pubmed.ncbi.nlm.nih.gov/32678845/
3. Yang, Meng-Nan, Huang, Rong, Zheng, Tao, Li, Jiong, Luo, Zhong-Cheng. 2022. Genome-wide placental DNA methylations in fetal overgrowth and associations with leptin, adiponectin and fetal growth factors. In Clinical epigenetics, 14, 192. doi:10.1186/s13148-022-01412-6. https://pubmed.ncbi.nlm.nih.gov/36585686/
4. Xiao, Guan-Yu, Mohanakrishnan, Aparna, Schmid, Sandra L. 2018. Role for ERK1/2-dependent activation of FCHSD2 in cancer cell-selective regulation of clathrin-mediated endocytosis. In Proceedings of the National Academy of Sciences of the United States of America, 115, E9570-E9579. doi:10.1073/pnas.1810209115. https://pubmed.ncbi.nlm.nih.gov/30249660/
5. Zhou, Chun, Fan, Xiaodan, Zhang, Junye. 2023. IRF3-mediated lncRNA FTX promotes cell proliferation, migration, invasion and suppresses cell apoptosis in oral squamous cell carcinoma by up-regulating FCHSD2 via miR-708-5p. In Cellular and molecular biology (Noisy-le-Grand, France), 69, 31-36. doi:10.14715/cmb/2023.69.2.6. https://pubmed.ncbi.nlm.nih.gov/37224049/
6. Singh, Purnima, Zhou, Liting, Shah, Disheet A, Burridge, Paul W, Bhatia, Smita. 2023. Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy. In Scientific reports, 13, 12683. doi:10.1038/s41598-023-39357-2. https://pubmed.ncbi.nlm.nih.gov/37542143/
智鼠故事 
